Deep Knowledge Group
Venture capital fund that invests in life sciences, cancer research, age-related diseases and regenerative medicine.
Deep Knowledge Group is a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, media, philanthropy and more.
The consortium include Deep Knowledge Ventures, Longevity.Capital, AI-Pharma.Capital, Longevity FinTech Company, Deep Knowledge Analytics, Aging Analytics Agency, NeuroTech Analytics, Biogerontology Research Foundation, Longevity Swiss Foundation, AI-Longevity Consortium at King’s College London, and Longevity International UK - Secretariat for the UK All Party Parliamentary Group for Longevity.
Visit website: https://www.dkv.global
Mentioned in this Resource
Provider of industry analytics on the topics of Longevity, Precision Preventive Medicine and Economics of Aging.
Group to address UK govt HLE +5 target
Non-profit company focused on Longevity industry and gerontology
Company that is investing in longevity.
Leading neurotech-focused analytical hub producing advanced analytical reports on the whole scope of neurotech industries.
Deep Knowledge Group Creations
Club’s launch event featured presentations and panel discussions by a number of Longevity Financial Industry professionals
Event about longevity and healthy life organized by Deep Knowledge Group
Other people at Deep Knowledge Group
Deputy Managing Partner at Deep Knowledge Group
Managing partner at Deep Knowledge Ventures
Strategic Director at Deep Knowledge Group, Director & CMO of Longevity Card
Head of Investor Relations at Deep Knowledge Group
Managing Partner at Deep Knowledge Group
Vice President Communications at Deep Knowledge Group
Director of Investor Relations for Europe an MENA regions at Deep Knowledge Group
Head of Structured Products and UK Operations at Deep Knowledge Ventures
Co-founder and Managing Partner of Deep Knowledge Group
Deep Knowledge Group News
DKG profile interview with its own Remus Stanescu, Director of Longevity Financial Advisors
Deep Knowledge Group - 12-Jan-2022
Highlights some nuances when investing in the longevity industry
Quant Biomarkers established to develop sophisticated analytical products
Quant Biomarkers - 10-Dec-2021
DKG subsidiary to introduce biomarker-driven Longevity risk mitigation and intervention support